CN1652758A - 使用文拉法辛和衍生物治疗胃肠和泌尿生殖疼痛症的方法 - Google Patents

使用文拉法辛和衍生物治疗胃肠和泌尿生殖疼痛症的方法 Download PDF

Info

Publication number
CN1652758A
CN1652758A CNA038112612A CN03811261A CN1652758A CN 1652758 A CN1652758 A CN 1652758A CN A038112612 A CNA038112612 A CN A038112612A CN 03811261 A CN03811261 A CN 03811261A CN 1652758 A CN1652758 A CN 1652758A
Authority
CN
China
Prior art keywords
carbon atoms
hydrogen
alkyl
disorder
functional gastrointestinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA038112612A
Other languages
English (en)
Chinese (zh)
Inventor
R·G·卡尔斯塔德特
R·B·林
M·S·伯顿
M·丹尼列维茨
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth LLC filed Critical Wyeth LLC
Publication of CN1652758A publication Critical patent/CN1652758A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CNA038112612A 2002-05-17 2003-05-15 使用文拉法辛和衍生物治疗胃肠和泌尿生殖疼痛症的方法 Pending CN1652758A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38130502P 2002-05-17 2002-05-17
US60/381,305 2002-05-17

Publications (1)

Publication Number Publication Date
CN1652758A true CN1652758A (zh) 2005-08-10

Family

ID=29550101

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA038112612A Pending CN1652758A (zh) 2002-05-17 2003-05-15 使用文拉法辛和衍生物治疗胃肠和泌尿生殖疼痛症的方法

Country Status (21)

Country Link
US (1) US20040019101A1 (https=)
EP (1) EP1505960A1 (https=)
JP (1) JP2005530779A (https=)
KR (1) KR20050003464A (https=)
CN (1) CN1652758A (https=)
AR (1) AR040033A1 (https=)
AU (1) AU2003232137A1 (https=)
BR (1) BR0310083A (https=)
CA (1) CA2485736A1 (https=)
CR (1) CR7568A (https=)
EC (1) ECSP045436A (https=)
IL (1) IL165216A0 (https=)
MX (1) MXPA04011329A (https=)
NO (1) NO20044868L (https=)
NZ (1) NZ548950A (https=)
RU (1) RU2004136999A (https=)
SG (1) SG165991A1 (https=)
TW (1) TW200402289A (https=)
UA (1) UA81413C2 (https=)
WO (1) WO2003097029A1 (https=)
ZA (1) ZA200410157B (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7402698B2 (en) * 2003-10-14 2008-07-22 Wyeth Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use
US7550485B2 (en) * 2003-10-14 2009-06-23 Wyeth Substituted N-heterocycle derivatives and methods of their use
US7524846B2 (en) * 2003-10-14 2009-04-28 Wyeth Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use
US7419980B2 (en) * 2003-10-14 2008-09-02 Wyeth Fused-aryl and heteroaryl derivatives and methods of their use
US7531543B2 (en) * 2003-10-14 2009-05-12 Wyeth Phenylpiperazine cycloalkanol derivatives and methods of their use
US7365076B2 (en) * 2003-10-14 2008-04-29 Wyeth Substituted aryl cycloalkanol derivatives and methods of their use
US7491723B2 (en) * 2003-10-14 2009-02-17 Wyeth Alkanol and cycloalkanol-amine derivatives and methods of their use
US20070142367A1 (en) * 2003-11-10 2007-06-21 Lundeen James E Method and medicine for treating gastrointestinal disorder including fecal incontinence
US20060148783A1 (en) * 2003-11-10 2006-07-06 Lundeen James E Method and medicine for treating gastrointestinal disorder including fecal incontinence
US20050113365A1 (en) * 2003-11-10 2005-05-26 Sir Isaac Newton Enterprises Llc Method and medicine for treating gastrointestinal disorder including irritable bowel syndrome
US20060148781A1 (en) * 2003-11-10 2006-07-06 Lundeen James E Method and medicine for treating gastrointestinal disorder in a non-human mammal
US20060148782A1 (en) * 2003-11-10 2006-07-06 Lundeen James E Method and medicine for treating a mammal presenting urinary incontinence, urinary urgency, or both
US7820690B2 (en) * 2004-03-19 2010-10-26 Solvay Pharmaceuticals Gmbh Method of treating or inhibiting a non-digestive tract derived abdominal disorder associated with pain using a 5-HT, receptor antagonist
US7414052B2 (en) * 2004-03-30 2008-08-19 Wyeth Phenylaminopropanol derivatives and methods of their use
US7517899B2 (en) * 2004-03-30 2009-04-14 Wyeth Phenylaminopropanol derivatives and methods of their use
US20080081067A1 (en) * 2006-10-03 2008-04-03 Gupta Manishkumar Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof
GB201007032D0 (en) * 2010-04-27 2010-06-09 Dormer Tools Ltd Twist drill for advanced materials
CN102095461B (zh) * 2011-01-18 2012-07-18 姚贤卿 复合型干度质量流量仪及干度标定测量方法
RU2740750C1 (ru) * 2020-03-27 2021-01-20 Аллан Герович Бениашвили Средство для лечения функциональных заболеваний желудочно-кишечного тракта

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
ES2208870T3 (es) * 1996-02-15 2004-06-16 Janssen Pharmaceutica N.V. Uso de antagonistas del receptor 5ht4 para resolver los efectos gastrointestinales de los inhibidores de la reabsorcion de serotonina.
US6579899B1 (en) * 1998-07-16 2003-06-17 Massachusetts Institute Of Technology Composition for treatment of stress
US6174882B1 (en) * 1998-11-23 2001-01-16 Sepracor Inc. 2-hydroxymethylolanzapine compositions and methods
ATE253364T1 (de) * 1998-11-23 2003-11-15 Sepracor Inc Olanzapin-n-oxide enthaltende pharmaceutische zusammensetzungen
PT1133300E (pt) * 1998-11-23 2005-04-29 Sepracor Inc Composicoes de desmetilolanzapina e metodos
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
GB2355191A (en) * 1999-10-12 2001-04-18 Laxdale Ltd Combination formulations for fatigue, head injury and strokes
US20030232805A1 (en) * 2002-04-24 2003-12-18 Cypress Bioscience, Inc. Prevention and treatment of functional somatic disorders, including stress-related disorders
NZ537142A (en) * 2002-06-10 2008-01-31 Wyeth Corp Novel formate salt of O-desmethyl-venlafaxine

Also Published As

Publication number Publication date
AU2003232137A1 (en) 2003-12-02
ECSP045436A (es) 2005-01-03
MXPA04011329A (es) 2005-02-14
CA2485736A1 (en) 2003-11-27
AR040033A1 (es) 2005-03-09
JP2005530779A (ja) 2005-10-13
RU2004136999A (ru) 2006-06-10
IL165216A0 (en) 2005-12-18
ZA200410157B (en) 2006-05-31
CR7568A (es) 2005-02-08
WO2003097029A1 (en) 2003-11-27
BR0310083A (pt) 2005-02-15
KR20050003464A (ko) 2005-01-10
NZ548950A (en) 2008-01-31
EP1505960A1 (en) 2005-02-16
TW200402289A (en) 2004-02-16
UA81413C2 (en) 2008-01-10
NO20044868L (no) 2004-12-08
SG165991A1 (en) 2010-11-29
US20040019101A1 (en) 2004-01-29

Similar Documents

Publication Publication Date Title
CN1652758A (zh) 使用文拉法辛和衍生物治疗胃肠和泌尿生殖疼痛症的方法
EP0639374B1 (en) New treatments using phenethyl derivatives
CN1137894A (zh) 顽发克星在治疗妇女非抑郁下丘脑性经闭中的应用
HU204504B (en) Process for producing phenoxy-bicyclo-amine derivatives and antidepressive pharmaceutical compositions containing them
BRPI0806608A2 (pt) métodos para prevenir ou reduzir o número de surtos agudos de gota utilizando inibidores xantina oxidoredutase e agentes anti-inflamatórios
KR20090021214A (ko) Ｃｇｒｐ-길항제에 의한 위장 장애의 치료
JP2021088575A5 (https=)
RU2314809C2 (ru) Способ лечения депрессии соединениями-агонистами дельта-рецепторов
CN1382145A (zh) 神经性疼痛治疗剂和神经性疼痛的动物模型
EP1123702A1 (en) Analgesics
EP0483152A1 (en) A method of reducing body weight and food intake using a dopamine d2 receptor agonist
AU2002241326B2 (en) Remedies for psychoneurosis
JP5042625B2 (ja) 抗炎症剤として有用なα−アミノアミド誘導体
EP2533774B1 (fr) Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement du trouble obsessionnel compulsif (toc)
CN1750826A (zh) R－10－羟基－10,11－二氢－卡马西平在神经病性疼痛中的应用
JP6067022B2 (ja) 情動障害の予防又は治療に用いるためのｎ−置換ベンゼンプロパンアミド又はベンゼンプロペンアミド
US5854248A (en) Nefazodone: use in migraine prophylaxis
US20080176951A1 (en) Methods of treating gastrointestinary and genitourinary pain disorders
JP5764327B2 (ja) 過敏性腸症候群（ｉｂｓ）を処置するための４−［２−（４−メチルフェニルスルファニル）フェニル］ピペリジン
JP2006021998A (ja) Ｅｐ２アゴニストを有効成分とする月経困難症治療剤
AU744990B2 (en) New treatment using phenethylamine derivatives
WO2004058353A2 (en) Therapeutic use of selective noradrenaline reuptake inhibitors
BRPI0616197A2 (pt) associaÇço de agonista aos receptores beta3 e de inibidores da recaptura de monoaminas, composiÇço farmacÊutica que as contÉm e a respectiva utilizaÇço terapÊutica
JP2004168692A (ja) ４−（２−フルオロフェニル）−６−メチル−２−（１−ピペラジニル）チエノ［２，３−ｄ］ピリミジンの新規な用途
HK1096872A (en) The combination of a serotonin reuptake inhibitors and agomelatine

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20050810